December 2023
1. JOHANN L, Soldati S, Muller K, Lampe J, et al
   A20 regulates lymphocyte adhesion in murine neuroinflammation by restricting endothelial ICOSL expression in the CNS.
   J Clin Invest. 2023;133:e168314.
   

   >> Share

   
   September 2023
2. CLARKSON BD, Grund EM, Standiford MM, Mirchia K, et al
   CD8+ T cells recognizing a neuron-restricted antigen injure axons in a model of multiple sclerosis.
   J Clin Invest. 2023 Sep 7:e162788. doi: 10.1172/JCI162788.
   

   >> Share

   
   August 2023
3. OWENS GP, Fellin TJ, Matschulat A, Salas V, et al
   Pathogenic myelin specific antibodies in multiple sclerosis target conformational proteolipid protein 1 anchored membrane domains.
   J Clin Invest. 2023 Aug 10:e162731. doi: 10.1172/JCI162731.
   

   >> Share

   
   May 2023
4. KERKERING J, Muinjonov B, Rosiewicz KS, Diecke S, et al
   iPSC-derived reactive astrocytes from patients with multiple-sclerosis protect cocultured neurons in inflammatory conditions.
   J Clin Invest. 2023 May 23:e164637. doi: 10.1172/JCI164637.
   

   >> Share

   
   
5. REDER AT
   Clostridium epsilon toxin is excessive in multiple sclerosis and provokes multifocal lesions in mouse models.
   J Clin Invest. 2023;133:e169643.
   

   >> Share

   
   
6. MA Y, Sannino D, Linden JR, Haigh S, et al
   Epsilon toxin-producing Clostridium perfringens colonize the multiple sclerosis gut microbiome overcoming CNS immune privilege.
   J Clin Invest. 2023;133:e163239.
   

   >> Share

   
   April 2023
7. ANTEL JP, Kennedy TE, Kuhlmann T
   Seeking neuroprotection in multiple sclerosis: an ongoing challenge.
   J Clin Invest. 2023;133:e168595.
   

   >> Share

   
   
8. KAPELL H, Fazio L, Dyckow J, Schwarz S, et al
   Neuron-oligodendrocyte potassium shuttling at nodes of Ranvier protects against inflammatory demyelination.
   J Clin Invest. 2023;133:e164223.
   

   >> Share

   
   October 2022
9. ASASHIMA H, Axisa PP, Pham THG, Longbrake EE, et al
   Impaired TIGIT expression on B cells drives circulating follicular helper T cell expansion in multiple sclerosis.
   J Clin Invest. 2022;132.
   

   >> Share

   
   September 2022
10. HORWITZ RI, Hayes-Conroy A, Singer BH, Cullen MR, et al
    Falling down the biological rabbit hole: Epstein-Barr virus, biography, and multiple sclerosis.
    J Clin Invest. 2022;132.
    

    >> Share

    
    May 2022
11. FUJIWARA M, Raheja R, Garo LP, Ajay AK, et al
    microRNA-92a promotes CNS autoimmunity by modulating the regulatory and inflammatory T cell balance.
    J Clin Invest. 2022;132.
    

    >> Share

    
    
12. TYLER KL
    The enigmatic links between Epstein-Barr virus infection and multiple sclerosis.
    J Clin Invest. 2022;132.
    

    >> Share

    
    July 2021
13. GHEZZI L, Cantoni C, Pinget GV, Zhou Y, et al
    Targeting the gut to treat multiple sclerosis.
    J Clin Invest. 2021;131.
    

    >> Share

    
    June 2021
14. SINGH AK, Netea MG, Bishai WR
    BCG turns 100: its nontraditional uses against viruses, cancer, and immunologic diseases.
    J Clin Invest. 2021;131.
    

    >> Share

    
    November 2020
15. POMPURA SL, Wagner A, Kitz A, Laperche J, et al
    Oleic acid restores suppressive defects in tissue-resident FOXP3 regulatory T cells from patients with multiple sclerosis.
    J Clin Invest. 2020 Nov 10. pii: 138519. doi: 10.1172/JCI138519.
    

    >> Share

    
    April 2020
16. LI Z, Korhonen EA, Merlini A, Strauss J, et al
    Angiopoietin-2 blockade ameliorates autoimmune neuroinflammation by inhibiting leukocyte recruitment into the CNS.
    J Clin Invest. 2020;130:1977-1990.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share